Ultime notizie per Fulgent Genetics (NASDAQ:FLGT) Azioni

Fulgent Genetics

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Fulgent Genetics Inc

<a href="https://www.theinformation.com/articles/google-convinces-openai-use-tpu-chips-win-nvidia" title="https://www.theinformation.com/articles/google-convinces-openai-use-tpu-chips-win-nvidia">https://www.theinformation.com/articles/google-convinces-openai-use-tpu-chips-win-nvidia</a>

News

GOOG

NVDA

'Google Convinces OpenAI To Use TPU Chips In Win Against Nvidia' - The Information

WIIM

GOOGL

Shares of Alphabet are trading higher following the Russell index's annual reconstitution and rebalancing, which takes place annually at the end of June.

Macro Economic Events

Politics

Global

Economics

General

Live On CNBC, U.S. Secretary of the Treasury Scott Bessent Says We Believe That Rare Earth Magnets Are Starting To Flow Again With China; When We Are Certain, We Will Drop Countermeasures; 20 Countries That Could Go Back To Reciprocal Tariffs, Or If We Think Negotiating In Good Faith They Could Stay At 10%

AMZN

Shares of Amazon are trading higher following the Russell index's annual reconstitution and rebalancing, which takes place annually at the end of June.

PLTR

Shares of Palantir are trading lower. The stock may be down following investor concerns about the company's valuation, as well as profit-taking from traders.

Live On CNBC, U.S. Secretary of the Treasury Scott Bessent Says As Of Monday, Canada Will Introduce A Retroactive Tax; My Inclination Is That USTR Will Start A 301 Investigation Into Digital Services Taxes; Think About $2B Retroactive Digital Service Taxes From Canada

Bexotegrast development in IPF discontinued
Clinical oncology program and early-stage programs continue
Recent workforce and operational changes align with next steps
SOUTH SAN FRANCISCO, Calif., June 27, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRX#NASDAQ">PLRX</a>) today announced that following the review of data from the recently terminated BEACON-IPF Phase 2b/3 clinical trial, the Company has discontinued development of bexotegrast in idiopathic pulmonary fibrosis (IPF).
BEACON-IPF Trial Update
BEACON-IPF was a randomized, double-blind, placebo-controlled, global Phase 2b/3 clinical trial evaluating patients with IPF. In March of this year, Pliant announced the voluntary discontinuation of BEACON-IPF following a prespecified data review and recommendation by the trial's independent Data Safety Monitoring Board (DSMB), as well as a secondary review and recommendation by an outside expert panel, citing an imbalance in IPF-related adverse events.
Following an analysis of the full safety and efficacy data from the BEACON-IPF trial, the Company is discontinuing development of bexotegrast in IPF. Results showed that at doses of 160 mg and 320 mg, bexotegrast demonstrated an unfavorable risk-benefit profile. Compared to placebo, bexotegrast-treated participants showed an increased risk of experiencing adverse events associated with IPF disease progression, defined as events of worsening of IPF and acute IPF exacerbation, respiratory-related hospitalization, and/or all-cause mortality. The average time to disease progression for bexotegrast-treated participants was 33 weeks, suggesting that the safety risk may not be apparent with shorter dosing duration as was the case in the prior INTEGRIS-IPF Phase 2a trial.&nbsp;
At Week 12, bexotegrast 160 mg and 320 mg treatment groups demonstrated improvements in forced vital capacity (FVC) decline of 72 mL (p&lt;0.05) and 46 mL (p&gt;0.05), respectively, compared to placebo. At Week 24, bexotegrast 160 mg and 320 mg treatment groups demonstrated improvements in FVC decline of 58 mL (p&gt;0.05) and 8 mL (p&gt;0.05), respectively, compared to placebo.
The full results from BEACON-IPF will be submitted for future publication.
Oncology Phase 1 Enrollment Continues
PLN-101095 is an oral, small molecule, dual selective inhibitor of αvβ8 and αvβ1 integrins, designed to block TGF-β activation in the tumor microenvironment. PLN-101095 is currently undergoing a Phase 1 open-label trial as monotherapy and in combination with pembrolizumab in patients with solid tumors that are resistant to immune checkpoint inhibitors. In March, the Company announced interim results from this trial showing that PLN-101095 was generally well tolerated with confirmed partial responses in 50% of patients at highest dose tested to date, across multiple tumor types. The trial is currently enrolling the fifth of five planned dose cohorts.
Early Programs Supported by Proprietary Platform
The Company's drug discovery platform consists of a proprietary library of over 15,000 integrin binding molecules, a comprehensive screening assay system (binding, integrin confirmation, ligand-induced internalization) and an advanced live human tissue program. The Company believes in the broad applicability of the platform across multiple disease areas including delivery of drug payloads to cells utilizing integrin receptor-binding molecules as tissue-specific delivery and internalization mechanisms.

PLRX

Pliant Therapeutics Discontinues Development Of Bexotegrast In Idiopathic Pulmonary Fibrosis After BEACON-IPF Phase 2b/3 Clinical Trial Review

Wall Street returned to record highs at the end of June, with both the S&amp;P 500 and Nasdaq 100 breaking above their February peaks, capping a powerful rebound from <a href="https://www.benzinga.com/markets/economic-data/25/06/46124290/sp-500-hits-record-highs-and-history-says-the-best-is-yet-to-come">April's tariff-driven lows.</a>
Investor sentiment turned positive as geopolitical and trade risks eased. Oil prices slumped $12 to $65 after a symbolic Iranian strike on a U.S. base in Qatar failed <a href="https://www.benzinga.com/markets/25/06/46101460/oil-was-supposed-to-soar-on-iran-strikes-it-just-crashed-instead">to escalate tensions further. </a>
President Donald Trump announced that a ceasefire between Israel and Iran had been established, effectively ending the 12-day conflict.
During his two-day testimony before Congress, Federal Reserve Chair Jerome Powell said this year's tariff hikes are likely to raise prices and weigh on the economy, warranting caution <a href="https://www.benzinga.com/markets/economic-data/25/06/46077396/powell-interest-rates-trump-inflation-tariffs">on interest rate cuts.</a>
Powell's neutral tone sparked renewed friction with President Trump, who continues to criticize the Fed chair and fuel speculation over a possible leadership change when Powell's term <a href="https://www.benzinga.com/news/25/06/46115346/trump-powell-fed-chairman-odds-dollar">ends in May 2026</a>.
Markets now anticipate that Trump's influence could lead to a more dovish pivot at the central bank. Traders are pricing in two rate cuts before year-end and persistent dollar weakness, with the U.S. Dollar Index falling to levels last seen in February 2022—before Russia's invasion of Ukraine—and heading for its worst <a href="https://www.benzinga.com/markets/economic-data/25/06/46146713/trump-dollar-outlook-tariffs-debt">half-year since 1991.</a>
The stock rally gained momentum at the end of the week as Commerce Secretary Howard Lutnick said the U.S. reached a trade agreement with China. Officials also signaled progress in trade talks with at least 10 other countries, suggesting a softening stance from the White House toward protectionist policies.
In corporate news, Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) surged to new record highs, reaching a market <a href="https://www.benzinga.com/content/46149573/nvidias-stock-price-hits-new-highs-this-is-whats-next">capitalization of $3.85 trillion. </a>
The AI-chip giant reclaimed the title of the world's most valuable publicly traded company, overtaking Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) once again amid continued dominance in the AI chip market. 
On Friday, Trump announced an abrupt halt to all trade negotiations with Canada, a key U.S. trading partner, due to a Digital Services Tax on U.S. corporations. The move halted the market&#8217;s strong gains during the session and raised investor anxiety ahead of July&#8217;s 9 tariff deadline.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/06/46150909/trump-canada-tariffs-dollar-deal">Trump Flips On Canada Trade Deal, Sending Shivers Through Wall Street</a> </li>
</ul>
Image created using artificial intelligence via Midjourney.

Equities

Government

Regulations

Federal Reserve

Tech

MSFT

Wall Street Soars To Record Highs, Nvidia Becomes World's Most Valuable Company: This Week In Markets

Offerings

System1 May Offer, Sell Up To $250M In Aggregate Of Class A Common Stock From Time To Time

The AZEK Company Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZEK#NYSE">AZEK</a>) ("AZEK" or the "Company"), the industry-leading manufacturer of beautiful, low-maintenance and environmentally sustainable outdoor living products, including TimberTech&#xAE; Decking and Railing, AZEK&#xAE; and Versatex&#xAE; Trim and StruXure&#xAE; pergolas, today announced that its stockholders have voted to approve all proposals related to the Company's proposed transaction with James Hardie Industries plc ("James Hardie") at its Special Meeting of Stockholders. As previously announced, under the terms of the merger agreement and subject to the completion of the transaction, AZEK stockholders will receive $26.45 in cash and 1.0340 ordinary shares of James Hardie to be listed on the New York Stock Exchange for each share of AZEK common stock owned.
The transaction is expected to close on or about July 1, 2025, subject to the satisfaction or waiver of the closing conditions set forth in the merger agreement.
Approximately 99.96% of the votes cast at the Special Meeting voted in favor of the proposal to adopt the merger agreement, representing approximately 75.78% of AZEK's total outstanding shares of common stock. The final vote results, as certified by the inspector of elections, will be filed on a Form 8-K filed with the U.S. Securities and Exchange Commission. &nbsp;

AZEK

AZEK Stockholders Approve Merger With James Hardie; Holders To Receive $26.45 Cash, 1.0340 Shares Per AZEK Share

As previously disclosed, on June&nbsp;22, 2023, Jazz Pharmaceuticals,&nbsp;Inc. ("Jazz") filed an Administrative Procedure Act ("APA") suit against the U.S. Food and Drug Administration (the "FDA"), the U.S. Department of Health and Human Services, the Secretary of Health and Human Services and the Commissioner of Food and Drugs in the United States District Court for the District of Columbia (the "D.C. Court") related to the New Drug Application for LUMRYZ. This suit alleged that the FDA's approval of LUMRYZ was an unlawful agency action and asked the D.C. Court to set aside FDA's approval of LUMRYZ.
&nbsp;
On October&nbsp;30, 2024, the D.C. Court granted the FDA and Avadel Pharmaceuticals plc's Motions for Summary Judgment with respect to the sole count in Jazz's complaint and denied Jazz's Motion for Summary Judgment regarding the same. On November&nbsp;15, 2024, Jazz filed a notice of appeal to the United States Court of Appeals for the District of Columbia Circuit (the "D.C. Court of Appeals") concerning the D.C. Court's October&nbsp;30, 2024 ruling.
&nbsp;
On June&nbsp;27, 2025, the D.C. Court of Appeals, in a unanimous decision, affirmed the D.C. Court's ruling and upheld the FDA's approval of LUMRYZ.

Legal

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

JAZZ

Avadel Pharmaceuticals Announces Appeals Court Unanimously Upholds FDA Approval Of LUMRYZ

LRFC

PTMN

Portman Ridge Finance Receives Shareholder Approval For Merger With Logan Ridge Finance Corporation

XENE

Xenon Pharma Added To Russell 3000 And Russell 2000 Indexes As Part Of Annual Reconstitution, Effective June 27, 2025

Exicure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) reported quarterly earnings of $0.49 per share. This is a 202.08 percent increase over losses of $(0.48) per share from the same period last year.

Earnings

XCUR

Exicure Q1 EPS $0.49 Up From $(0.48) YoY

Financial giants have made a conspicuous bullish move on MongoDB. Our analysis of options history for MongoDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) revealed 12 unusual trades.
Delving into the details, we found 58% of traders were bullish, while 41% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $903,187, and 7 were calls, valued at $282,793.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $150.0 to $250.0 for MongoDB over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for MongoDB's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across MongoDB's significant trades, within a strike price range of $150.0 to $250.0, over the past month.
<h3>MongoDB Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751054527_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MDB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$18.55</td>
<td>$18.5</td>
<td>$18.5</td>
<td>$220.00</td>
<td>$377.2K</td>
<td align="right">736</td>
<td align="right">410</td>
</tr>
<tr>
<td>MDB</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/21/25</td>
<td>$5.25</td>
<td>$4.8</td>
<td>$5.1</td>
<td>$150.00</td>
<td>$255.0K</td>
<td align="right">193</td>
<td align="right">500</td>
</tr>
<tr>
<td>MDB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$18.35</td>
<td>$17.95</td>
<td>$18.32</td>
<td>$220.00</td>
<td>$182.8K</td>
<td align="right">736</td>
<td align="right">105</td>
</tr>
<tr>
<td>MDB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$17.7</td>
<td>$17.5</td>
<td>$17.5</td>
<td>$180.00</td>
<td>$61.2K</td>
<td align="right">165</td>
<td align="right">40</td>
</tr>
<tr>
<td>MDB</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/17/27</td>
<td>$79.1</td>
<td>$77.65</td>
<td>$79.1</td>
<td>$200.00</td>
<td>$55.3K</td>
<td align="right">55</td>
<td align="right">10</td>
</tr>
</tbody>
</table>

<h3>About MongoDB</h3>
Founded in 2007, MongoDB is a vendor of a document-oriented database that accelerates development processes of new applications. Enterprise customers can choose between the fully managed offering, MongoDB Atlas, or the self-managed version, MongoDB Enterprise Advanced. MongoDB is a popular tool among developers, and its free Community Server has recorded over 500 million downloads since 2009.
In light of the recent options history for MongoDB, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of MongoDB</h3>
<ul>
<li>With a trading volume of 1,138,381, the price of MDB is down by -0.39%, reaching $208.38.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 62 days from now.</li>
</ul>
<h3>What Analysts Are Saying About MongoDB</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $280.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Overweight rating for MongoDB, targeting a price of $275. 
&#x2A; Consistent in their evaluation, an analyst from Macquarie keeps a Neutral rating on MongoDB with a target price of $230. 
&#x2A; An analyst from Wedbush has revised its rating downward to Outperform, adjusting the price target to $300. 
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on MongoDB with a target price of $275. 
&#x2A; In a cautious move, an analyst from RBC Capital downgraded its rating to Outperform, setting a price target of $320. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for MongoDB with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

Markets

Market Whales and Their Recent Bets on MDB Options

Whales with a lot of money to spend have taken a noticeably bullish stance on Cipher Mining.
Looking at options history for Cipher Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIFR#NASDAQ">CIFR</a>) we detected 16 trades.
If we consider the specifics of each trade, it is accurate to state that 68% of the investors opened trades with bullish expectations and 25% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $438,653 and 13, calls, for a total amount of $722,886.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $3.0 to $7.0 for Cipher Mining during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Cipher Mining stands at 5017.67, with a total volume reaching 28,836.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Cipher Mining, situated within the strike price corridor from $3.0 to $7.0, throughout the last 30 days.
<h3>Cipher Mining Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751054521_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CIFR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$0.99</td>
<td>$0.75</td>
<td>$0.75</td>
<td>$3.50</td>
<td>$273.9K</td>
<td>1.8K</td>
<td>5.8K</td>
</tr>
<tr>
<td>CIFR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$0.52</td>
<td>$0.49</td>
<td>$0.52</td>
<td>$3.00</td>
<td>$128.3K</td>
<td>182</td>
<td>3.0K</td>
</tr>
<tr>
<td>CIFR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$0.91</td>
<td>$0.65</td>
<td>$0.65</td>
<td>$7.00</td>
<td>$117.8K</td>
<td>9.4K</td>
<td>187</td>
</tr>
<tr>
<td>CIFR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$0.63</td>
<td>$0.58</td>
<td>$0.63</td>
<td>$5.00</td>
<td>$100.8K</td>
<td>10.1K</td>
<td>4.1K</td>
</tr>
<tr>
<td>CIFR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$2.07</td>
<td>$1.66</td>
<td>$1.98</td>
<td>$5.00</td>
<td>$99.0K</td>
<td>12.7K</td>
<td>582</td>
</tr>
</tbody>
</table>

<h3>About Cipher Mining</h3>
Cipher Mining Inc ia an emerging technology company that operates in the Bitcoin mining ecosystem in the United States. The company is developing a cryptocurrency mining business, specializing in Bitcoin. The company is expanding and strengthening the Bitcoin network's critical infrastructure in the United States.
Following our analysis of the options activities associated with Cipher Mining, we pivot to a closer look at the company's own performance.
<h3>Current Position of Cipher Mining</h3>
<ul>
<li>With a volume of 55,072,968, the price of CIFR is up 1.67% at $4.26. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 46 days.</li>
</ul>
<h3>What The Experts Say On Cipher Mining</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $6.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Cantor Fitzgerald has decided to maintain their Overweight rating on Cipher Mining, which currently sits at a price target of $6. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Cipher Mining options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

CIFR

Cipher Mining Unusual Options Activity For June 27

Investors with a lot of money to spend have taken a bearish stance on SoFi Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with SOFI, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 54 uncommon options trades for SoFi Technologies.
This isn't normal.
The overall sentiment of these big-money traders is split between 38% bullish and 48%, bearish.
Out of all of the special options we uncovered, 15 are puts, for a total amount of $1,657,805, and 39 are calls, for a total amount of $1,790,585.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $7.0 to $35.0 for SoFi Technologies during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for SoFi Technologies's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across SoFi Technologies's significant trades, within a strike price range of $7.0 to $35.0, over the past month.
<h3>SoFi Technologies 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751054516_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SOFI</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/21/25</td>
<td>$2.91</td>
<td>$2.38</td>
<td>$2.7</td>
<td>$18.00</td>
<td>$648.0K</td>
<td>41</td>
<td>2.4K</td>
</tr>
<tr>
<td>SOFI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$0.61</td>
<td>$0.6</td>
<td>$0.61</td>
<td>$17.00</td>
<td>$183.0K</td>
<td>1.0K</td>
<td>2.9K</td>
</tr>
<tr>
<td>SOFI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$0.64</td>
<td>$0.62</td>
<td>$0.63</td>
<td>$15.00</td>
<td>$166.7K</td>
<td>6.2K</td>
<td>5.4K</td>
</tr>
<tr>
<td>SOFI</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$1.22</td>
<td>$1.2</td>
<td>$1.21</td>
<td>$16.00</td>
<td>$157.3K</td>
<td>2.2K</td>
<td>1.9K</td>
</tr>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$2.16</td>
<td>$2.05</td>
<td>$2.13</td>
<td>$30.00</td>
<td>$125.5K</td>
<td>18.4K</td>
<td>984</td>
</tr>
</tbody>
</table>

<h3>About SoFi Technologies</h3>
SoFi is a financial-services company that was founded in 2011 and is based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020, the company also offers payment and account services for debit cards and digital banking.
In light of the recent options history for SoFi Technologies, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>SoFi Technologies's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 82,991,512, the SOFI's price is up by 2.59%, now at $17.2. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 32 days.</li>
</ul>
<h3>What The Experts Say On SoFi Technologies</h3>
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $14.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Truist Securities downgraded its rating to Hold, setting a price target of $14. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for SoFi Technologies with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

SOFI

Behind the Scenes of SoFi Technologies's Latest Options Trends

PENN Entertainment's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PENN#NYSE">PENN</a>) short percent of float has risen 3.74% since its last report. The company recently reported that it has 20.62 million shares sold short, which is 13.87% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.18 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>PENN Entertainment Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751054427_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for PENN Entertainment has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing PENN Entertainment's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, PENN Entertainment's peer group average for short interest as a percentage of float is 5.25%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

PENN

Peering Into PENN Entertainment's Recent Short Interest

Palomar Hldgs's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLMR#NYSE">PLMR</a>) short percent of float has fallen 4.17% since its last report. The company recently reported that it has 507 thousand shares sold short, which is 2.3% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.74 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Palomar Hldgs Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751054422_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Palomar Hldgs has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Palomar Hldgs's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Palomar Hldgs's peer group average for short interest as a percentage of float is 5.54%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

PLMR

Is Palomar Hldgs Gaining or Losing Market Support?

East West Bancorp's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NYSE">EWBC</a>) short percent of float has risen 7.45% since its last report. The company recently reported that it has 5.44 million shares sold short, which is 4.47% of all regular shares that are available for trading. Based on its trading volume, it would take traders 7.94 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>East West Bancorp Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751054417_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for East West Bancorp has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing East West Bancorp's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, East West Bancorp's peer group average for short interest as a percentage of float is 4.28%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

EWBC

What Does the Market Think About East West Bancorp?

Press Releases

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT

Bragar Eagel & Squire, P.C. Is Investigating EchoStar, Semler, ADTRAN, and Fulgent and Encourages Investors to Contact the Firm

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT

Bragar Eagel & Squire, P.C. Is Investigating Semler, ADTRAN, and Fulgent and Encourages Investors to Contact the Firm

ADTN

FLGT

SATS

SMLR

Agilon Health

AirSculpt Technologies, Inc. - Common Stock

AirSculpt Technologies

AMN Healthcare Services

Astrana Health

Aveanna Healthcare Holdings Inc. - Common Stock

Aveanna Healthcare Hldgs

Concord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) Class A ordinary shares)

Comments

Fulgent Genetics

Notizie

Ultime notizie per Fulgent Genetics (NASDAQ:FLGT) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO